Clinical Trial Update: Efficacy and Safety of Avatrombopag vs. Avatrombopag Combined With rhTPO in the Treatment of SAA [Phase 2]

View source ↗

Summary

Phase 2 trial comparing avatrombopag alone versus avatrombopag with rhTPO for anemia due to aplastic anemia, focusing on efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Aplastic Anemia

Drugs mentioned

• Avatrombopag (avatrombopag)
• rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Anemia, Aplastic | Phase 2 | Status: UNKNOWN